Genpact Limited — Q2 2023 Form 10-Q Summary
Business context and reporting period
Genpact Limited is a global professional services company providing digitally led innovation, analytics, consulting, digital solutions, business process management and information technology services. It had more than 121,000 employees operating in over 35 countries. This unaudited Form 10-Q covers the three and six months ended June 30, 2023, compared with the same periods in 2022. The company is organized into Financial Services, Consumer and Healthcare, and High Tech and Manufacturing segments.
Key financial metrics
| Metric | Q2 2023 | Q2 2022 | Change |
|---|---|---|---|
| Net revenue | $1,105.5 million | $1,089.1 million | 1.5% increase |
| Gross profit | $390.0 million | $374.9 million | 4.0% increase |
| Gross margin | 35.3% | 34.4% | 90 basis-point increase |
| Income from operations | $157.3 million | $109.7 million | 43.4% increase |
| Operating margin | 14.2% | 10.1% | 410 basis-point increase |
| Net income | $116.3 million | $71.7 million | 62.2% increase |
| Net margin | 10.5% | 6.6% | 390 basis-point increase |
| Diluted EPS | $0.63 | $0.38 | Increase |
| Adjusted income from operations | $186.0 million | $182.8 million | 1.7% increase |
| Adjusted operating margin | 16.8% | 16.9% | 10 basis-point decrease |
For the six months ended June 30, 2023, revenue was $2,194.8 million, up 1.7%; income from operations was $302.4 million, up 24.2%; net income was $222.4 million, up 32.5%; diluted EPS was $1.19 versus $0.89; and adjusted income from operations was approximately $365.0 million versus $342.8 million.
Revenue and segment performance
- Q2 Data-Tech-AI revenue increased 2.5% to $500.7 million, while Digital Operations revenue increased 0.7% to $604.8 million. On a constant-currency basis, total Q2 revenue growth was 2.7%.
- Q2 Financial Services revenue increased 4.5% to $301.4 million, supported by insurance services and digital solutions.
- Q2 Consumer and Healthcare revenue decreased 1.5% to $394.9 million, reflecting longer deal cycles and the divestiture of a business previously classified as held for sale.
- Q2 High Tech and Manufacturing revenue increased 2.3% to $409.2 million, driven by supply-chain engagements and client deal ramp-ups, partially offset by reduced scope for a large client.
- Management cited demand for supply-chain solutions, automation of finance and accounting processes, and ramp-ups of existing and recently signed client engagements as growth drivers. Discretionary client spending and longer sales cycles remained constraints.
Cash flow, liquidity and debt
- Cash provided by operating activities was $137.4 million in the first half of 2023, compared with cash used of $11.9 million in the first half of 2022. The improvement primarily reflected higher net income and improved working-capital flows.
- Cash used in investing activities was $45.9 million, including $19.5 million related to the divestiture of a business and $24.0 million for property, plant and equipment.
- Cash used in financing activities was $257.7 million, including $150.5 million for share repurchases and $50.3 million for dividends.
- Cash and cash equivalents declined to $491.3 million at June 30, 2023 from $646.8 million at December 31, 2022. Approximately $488.8 million was held by foreign subsidiaries.
- Short-term borrowings were $103.0 million. Long-term debt was $1,262.8 million, comprising a $515.3 million term loan, $399.2 million of 2019 Senior Notes and $348.3 million of 2021 Senior Notes.
- The 2019 Senior Notes mature December 1, 2024; the 2021 Senior Notes mature April 10, 2026; and the term loan and revolving credit facility mature December 13, 2027. The company was in compliance with its debt covenants, including net debt to EBITDA below 3x and interest coverage above 3x.
- The $650.0 million revolving credit facility had $103.0 million of funded borrowings outstanding at June 30, 2023. Interest-rate swaps covered $418.0 million of notional floating-rate debt exposure.
- Management expects operating cash flow, cash reserves and debt capacity to be sufficient for the next twelve months and the foreseeable future to fund operations, growth, dividends and additional repurchases.
Material changes versus the prior comparable period
- Profitability improved substantially in Q2, partly because Q2 2022 included a $38.8 million restructuring charge, including lease-abandonment and severance costs. Q2 2023 included a $4.9 million gain from terminating an abandoned lease.
- Q2 2023 SG&A expense decreased 1.6% to $229.4 million, while acquired-intangible amortization decreased 24.2% to $8.3 million.
- First-half gross margin declined to 34.6% from 35.1%, primarily due to talent replacement costs, wage inflation, severance and travel expenses.
- The company completed the divestiture of a Consumer and Healthcare business in February 2023. The transaction generated a $0.8 million loss on sale and a $19.5 million investing cash outflow during the first half.
- Share repurchases totaled $150.5 million during the first half, and 3.8 million shares were repurchased and retired. The company had $474.5 million remaining under its authorization at June 30, 2023.
- The quarterly dividend increased 10% to $0.1375 per share, or a planned annualized rate of $0.55 per share. A $0.1375 per-share dividend for Q3 2023 was declared after quarter-end.
Guidance, outlook, commentary and risks
The filing does not provide a clear numerical revenue or earnings guidance range. Management expects investments in sales, marketing, research and development, and resources for new large deals to increase during the remainder of 2023. It also expects continued economic uncertainty, wage inflation, potential slowing global growth and foreign-exchange volatility to affect results.
- Key operating risks include client spending reductions, lengthening deal cycles, pricing pressure, employee attrition, wage inflation, hiring and retention challenges, competition and the ability to convert bookings into revenue.
- The company is exposed to foreign-exchange, interest-rate, credit, cybersecurity, data-protection, technology-disruption and geopolitical risks, including potential effects from the Russia-Ukraine conflict.
- India-related contingencies include possible retrospective employee benefit contributions and tax assessments totaling approximately $112.8 million, excluding subsequent interest and penalties. Management believes it is more likely than not to prevail in the tax matters and has recorded no reserve.
- The company had $24.5 million of unrecognized tax benefits at June 30, 2023, which could affect the effective tax rate if recognized.
- A potential earn-out of up to $10.6 million related to the divested business was not recorded because achievement was considered uncertain.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting during the quarter.
Most important facts for investors to verify
- Whether low reported revenue growth accelerates, particularly in Digital Operations and the Consumer and Healthcare segment.
- Whether first-half pressure from wage inflation, talent replacement, severance and travel costs persists and affects gross margin.
- The sustainability of operating cash flow after the significant improvement from the prior-year period.
- Liquidity and refinancing plans ahead of the December 2024 maturity of the $400 million 2019 Senior Notes.
- The effect of floating-rate debt, SOFR movements, credit-rating changes and hedge coverage on future interest expense.
- Progress on the remaining $474.5 million share-repurchase authorization and the company’s ability to fund repurchases and dividends while reducing debt.
- Developments in the Indian tax assessments and employee-benefit contingency, including any required reserves or cash payments.
- Whether management’s expectations for new deal ramps, AI and digital-services demand, and investment returns are realized.